Immunohistochemistry of COUP-TFI: An adjuvant diagnostic tool for the identification of corticotroph microadenomas

Pituitary

Volumn 13, Issue 1, 2010, Pages 1-7

  Bush, Zachary M ^a   Lopes, Maria Beatriz S ^a   Hussaini, Isa M ^a   Jane Jr , John A ^a   Laws Jr , Edward R ^b   Vance, Mary Lee ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Corticotroph; COUP TFI; Cushing's; Diagnosis; Pathology

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1;

ACTH SECRETING ADENOMA; ACTH SECRETING CELL; ADENOHYPOPHYSIS; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; WESTERN BLOTTING;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; COUP TRANSCRIPTION FACTOR I; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR DIAGNOSTIC TECHNIQUES; RETROSPECTIVE STUDIES; TISSUE DISTRIBUTION;

EID: 77949270312     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-009-0189-8     Document Type: Article

References (37)

1. K Kovacs 2001 Classification of pituitary adenomas J Neurooncology 54 121 127 10.1023/A:1012945129981 1:STN:280:DC%2BD38%2Fjtl2kuw%3D%3D (Pubitemid 33089245)
2. TR Prezant S Melmed 2002 Molecular pathogenesis of pituitary disorders Curr Opin Endocrinol and Diabetes 9 61 78 10.1097/00060793-200202000-00009 1:CAS:528:DC%2BD38Xnt1alu78%3D (Pubitemid 34747891)
3. WE Farrell RN Clayton 2003 Epigenetic change in pituitary tumorigenesis Endocr Relat Cancer 10 323 330 10.1677/erc.0.0100323 1:CAS:528: DC%2BD3sXmsFCrs7s%3D 12790793 (Pubitemid 36758658)
4. S Melmed 2003 Mechanisms for pituitary tumorigenesis: the plastic pituitary J Clin Invest 112 1603 1618 1:CAS:528:DC%2BD3sXpslensr0%3D 14660734
5. J Newell-Price P Trainer M Besser A Grossman 1998 The diagnosis and differential diagnosis of Cushing's syndrome and Pseudo-Cushing's states Endocr Rev 19 647 672 10.1210/er.19.5.647 1:CAS:528:DyaK1cXntV2rtbs%3D 9793762 (Pubitemid 28467716)
6. B Catargi V Rigalleau A Poussin N Ronci-Chaix V Bex V Vergnot, et al. 2003 Occult Cushing's syndrome in Type-2 diabetes J Clin Endocrinol Metab 88 12 5808 5813 10.1210/jc.2003-030254 1:CAS:528:DC%2BD3sXhtVSgsr3P 14671173 (Pubitemid 38033055)
7. JW Findling H Raff 2006 Cushing's Syndrome: important issues in diagnosis and management J Clin Endocrinol Metab 91 3746 3753 10.1210/jc.2006-0997 1:CAS:528:DC%2BD28XhtFSjtLbF 16868050 (Pubitemid 44536836)
8. J Newell-Price X Bertagna AB Grossman LK Nieman 2006 Cushing's syndrome The Lancet 367 9522 1605 1617 10.1016/S0140-6736(06)68699-6 1:CAS:528: DC%2BD28XksFygurc%3D (Pubitemid 43674231)
9. HA Tran N Petrovsky 2006 Difficulties in excluding Cushing syndrome in obese subjects The Endocrinologist 16 15 19 10.1097/01.ten.0000191747.48192.fb (Pubitemid 44378686)
10. G Arnaldi A Angeli AB Atkinson X Bertagna F Cavagnini GP Chrousos, et al. 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement J Clin Endocrinol Metab 88 5593 5602 10.1210/jc.2003-030871 1:CAS:528: DC%2BD3sXhtVShu7fL 14671138 (Pubitemid 38033020)
11. H Raff JL Raff JW Findling 1998 Late-night salivary cortisol as a screening test for Cushing's syndrome J Clin Endocrinol Metab 83 2681 2686 10.1210/jc.83.8.2681 1:CAS:528:DyaK1cXltlWnu74%3D 9709931 (Pubitemid 28493760)
12. DA Papanicolaou N Mullen I Kyrou LK Nieman 2002 Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome J Clin Endocrinol Metab 87 4515 4521 10.1210/jc.2002-020534 1:CAS:528: DC%2BD38XnvFCku7c%3D 12364428 (Pubitemid 35247034)
13. CE Martinelli SL Sader EB Oliveira JC Daneluzzi AC Moreira 1998 Salivary cortisol for screening of Cushing's syndrome in children Clin Endocrinol 51 67 71 10.1046/j.1365-2265.1999.00749.x
14. D Bochicchio M Losa M Buchfelder 1995 Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's disease survey group J Clin Endocrinol Metab 80 3114 3120 10.1210/jc.80.11.3114 1:CAS:528:DyaK2MXptleitL4%3D 7593411
15. PL Semple ML Vance JW Findling ER Laws 2000 Transsphenoidal Surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan Neurosurgery 46 553 559 10.1097/00006123-200003000-00005
16. C Invitti FP Giraldi M De Martin F Cavagnini 1999 Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study J Clin Endocrinol Metab 84 440 448 10.1210/jc.84.2.440 1:STN:280:DyaK1M7ksV2qtA%3D%3D 10022398 (Pubitemid 29075666)
17. JA Jane ER Laws 2001 The surgical management of pituitary adenomas in a series of 3, 093 patients J Am Coll Surg 193 650 659 10.1016/S1072-7515(01) 01101-2
18. CG Patil DM Prevedello SP Lad ML Vance MO Thorner L Katznelson, et al. 2008 Late recurrences of Cushing's disease after initial successful transsphenoidal surgery J Clin Endocrinol Metab 93 358 362 10.1210/jc.2007-2013 1:CAS:528:DC%2BD1cXit1Sntrk%3D 18056770 (Pubitemid 351246675)
19. RB Friedman EH Oldfield LK Nieman GP Chrousos JL Doppman GB Cutler Jr, et al. 1989 Repeat transsphenoidal surgery for Cushing's disease J Neurosurg 71 520 527 10.3171/jns.1989.71.4.0520 1:STN:280:DyaK3c%2FhtFaqtA%3D%3D 2552045
20. ® radiosurgery safe? Nat Clin Pract Endocrinol Metab 1 1 3 10.1038/ncpendmet0015
21. D Engelhardt MM Weber 1994 Therapy of Cushing's syndrome with steroid biosynthesis inhibitors 106 J Steroid Biochem Mol Biol 49 261 267 10.1016/0960-0760(94)90267-4 1:CAS:528:DyaK2cXkvFyqs7c%3D 8043488 (Pubitemid 24240610)
22. N Sonino M Boscaro 1999 Medical therapy for Cushing's disease Endocrinol Metab Clin North Am 28 211 222 10.1016/S0889-8529(05)70064-5 1:CAS:528:DyaK1MXis1Cnt7Y%3D 10207692 (Pubitemid 29164785)
23. J Naoumenko I Feigin 1974 A simple silver solution for staining reticulin Biotech Histochem 49 153 155 10.3109/10520297409116967 1:CAS:528: DyaE2cXksVOju78%3D
24. M Paez-Pereda D Kovalovsky U Hopfner M Theodoropoulou U Pagotto E Uhl, et al. 2001 Retinoic acid prevents experimental Cushing syndrome J Clin Invest 108 1123 1131 1:CAS:528:DC%2BD3MXns1Chs7g%3D 11602619
25. SM Hsu L Raine H Fanger 1981 The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques Am J Clin Pathol 75 816 821 1:CAS:528:DyaL3MXlt1yksb4%3D 6167159
26. AJ Norton S Jordan P Yeomans 1994 Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues J Pathol 173 371 379 10.1002/path.1711730413 1:STN:280:DyaK2M%2FlsVOnsA%3D%3D 7965396
27. PK Smith RI Krohn GT Hermanson AK Mallia FH Gartner MD Provenzano, et al. 1985 Measurement of protein using bicinchoninic acid Anal Biochem 150 76 85 10.1016/0003-2697(85)90442-7 1:CAS:528:DyaL2MXlsFKksL0%3D 3843705 (Pubitemid 16258399)
28. FA Pereira MJ Tsai SY Tsai 2000 COUP-TF orphan nuclear receptors in development and differentiation Cell Mol Life Sci 57 1388 1398 10.1007/PL00000624 1:CAS:528:DC%2BD3cXnvF2itL4%3D 11078018
29. SA Kliewer K Umesono RA Heyman DJ Mangelsdorf JA Dyck RM Evans 1992 Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling Proc Natl Acad Sci 89 1448 1452 10.1073/pnas.89.4.1448 1:CAS:528:DyaK38XhsVCrs7o%3D 1311101
30. E Ben Shushan H Sharir E Pikarsky Y Bergman 1995 A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells Mol Cell Biol 15 1034 1048 1:CAS:528:DyaK2MXjtlantL0%3D 7823919
31. DJ Mangelsdorf RM Evans 1995 The RXR heterodimers and orphan receptors Cell 83 841 850 10.1016/0092-8674(95)90200-7 1:CAS:528:DyaK2MXhtVSnu7nK 8521508 (Pubitemid 26006526)
32. HJ Kang MR Song SK Lee EC Shin YH Choi SJ Kim, et al. 2000 Retinoic acid and its receptors repress the expression and transactivation functions of Nur77: a possible mechanism for the inhibition of apoptosis by retinoic acid Exp Cell Res 256 545 554 10.1006/excr.2000.4832 1:CAS:528:DC%2BD3cXisFeltbc%3D 10772826 (Pubitemid 30244212)
33. V Castillo D Giacomini M Paez-Pereda J Stalla M Labeur M Theodoropoulou, et al. 2006 Retinoic acid as a novel medical therapy for Cushing's disease in dogs Endocrinology 147 4438 4444 10.1210/en.2006-0414 1:CAS:528: DC%2BD28Xpt1Sju7g%3D 16740975 (Pubitemid 44268395)
34. PLM Dahia AB Grossman 1999 The molecular pathogenesis of corticotroph tumors Endocr Rev 20 136 155 10.1210/er.20.2.136 1:CAS:528:DyaK1MXisFygsrs%3D 10204115 (Pubitemid 29339589)
35. J Drouin S Bilodeau S Vallette 2007 Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency Clin Genet 72 175 182 10.1111/j.1399-0004.2007.00877.x 1:STN:280:DC%2BD2srgtVymsg%3D%3D 17718852 (Pubitemid 47300017)
36. V Herman J Fagin R Gonsky K Kovacs S Melmed 1990 Clonal origin of pituitary adenomas J Clin Endocrinol Metab 71 1427 1433 10.1210/jcem-71-6-1427 1:STN:280:DyaK3M%2FjsFymuw%3D%3D 1977759
37. G Allenby M Bocquel M Saunders S Kazmer J Speck M Rosenberger, et al. 1993 Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids Proc Natl Acad Sci 90 30 34 10.1073/pnas.90.1.30 1:CAS:528:DyaK3sXhtFOntL4%3D 8380496 (Pubitemid 23010243)